CLINICAL_TRIALS
research
· 2016-08-22
Clinical Trial Update: MR-targeted vs. Random TRUS-guided Prostate Biopsy [NA]
Summary
An update on an ongoing trial comparing MR-targeted prostate biopsy with random TRUS-guided biopsy for detecting prostate cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Fondazione del Piemonte per l'Oncologia | Conditions: Prostate Cancer | NA | Status: UNKNOWN